StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · SNN·Healthcare

Smith & Nephew plc Stock Analysis & AI Score

Smith & Nephew plc (SNN) has an ST Score of 48.0 (C+), driven by its Profitability (A) and held back by its Momentum (D+). Analysts rate it Hold with a $31.91 price target (+19.6% upside).

Market Closed
$26.68
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
48
ST Score
48.0/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SNN
48.0out of 100
Grade C+

Smith & Nephew plc (SNN) has an ST Score of 48.0 (C+), driven by its Profitability (A) and held back by its Momentum (D+). Analysts rate it Hold with a $31.91 price target (+19.6% upside).

Strongest
ProfitabilityA
Weakest
MomentumD+
All factor grades
  • ProfitabilityA
  • GrowthC
  • ForecastC
  • Financial StrengthC-
  • ValuationD+
  • MomentumD+
  • Piotroski8/9
Score methodology
Press Releases

Contact

SNN stock: frequently asked questions

What is SNN's ST Score?

Smith & Nephew plc (SNN) has an ST Score of 48.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SNN a buy, hold, or sell?

Analysts rate SNN a Hold, with a price target of $31.91 (+19.6% vs the current price). Our ST Score grades it C+ (48.0/100). The ST Score is a data-driven signal, not a recommendation.

What are SNN's factor grades?

Valuation D+, Profitability A, Financial Strength C-, Momentum D+, Growth C, Forecast C.

What is SNN's valuation grade?

Smith & Nephew plc (SNN) earns a valuation grade of D+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SNN's growth grade?

Smith & Nephew plc (SNN) earns a growth grade of C, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SNN's profitability grade?

Smith & Nephew plc (SNN) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SNN's financial strength grade?

Smith & Nephew plc (SNN) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for SNN?

The average analyst price target for Smith & Nephew plc (SNN) is $31.91 from 23 analysts, which is +19.6% versus the recent price of $26.68.

What is SNN's Piotroski score?

Smith & Nephew plc (SNN) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.